These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2730708

  • 1. Platelet activation by oxidatively modified low density lipoproteins.
    Ardlie NG, Selley ML, Simons LA.
    Atherosclerosis; 1989 Apr; 76(2-3):117-24. PubMed ID: 2730708
    [Abstract] [Full Text] [Related]

  • 2. The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity.
    Vlasova II.
    Platelets; 2000 Nov; 11(7):406-14. PubMed ID: 11132108
    [Abstract] [Full Text] [Related]

  • 3. Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins.
    Takahashi Y, Chiba H, Matsuno K, Akita H, Hui SP, Nagasaka H, Nakamura H, Kobayashi K, Tandon NN, Jamieson GA.
    Biochem Biophys Res Commun; 1996 May 15; 222(2):453-9. PubMed ID: 8670226
    [Abstract] [Full Text] [Related]

  • 4. Arachidonate transfer between platelets and lipoproteins.
    Surya II, Gorter G, Akkerman JW.
    Thromb Haemost; 1992 Dec 07; 68(6):719-26. PubMed ID: 1287888
    [Abstract] [Full Text] [Related]

  • 5. Mildly oxidized LDL induces platelet aggregation through activation of phospholipase A2.
    Weidtmann A, Scheithe R, Hrboticky N, Pietsch A, Lorenz R, Siess W.
    Arterioscler Thromb Vasc Biol; 1995 Aug 07; 15(8):1131-8. PubMed ID: 7627706
    [Abstract] [Full Text] [Related]

  • 6. Abnormalities in platelets and vascular endothelial cells induced by glycated lipoproteins.
    Takeda H, Yano T, Kishikawa H, Miyata T, Shinohara M, Yamaguchi E, Kobori S, Fan JL, Tokunaga O, Shichiri M.
    Intern Med; 1992 Jun 07; 31(6):746-51. PubMed ID: 1392175
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasma lipoproteins affect platelet malondialdehyde and thromboxane B2 production.
    Aviram M, Sirtori CR, Colli S, Maderna P, Morazzoni G, Tremoli E.
    Biochem Med; 1985 Aug 07; 34(1):29-36. PubMed ID: 4052061
    [Abstract] [Full Text] [Related]

  • 9. Stimulating effect of biologically modified low density lipoproteins on ADP-induced aggregation of washed platelets persists in absence of specific binding.
    Volf I, Roth A, Moeslinger T, Cooper J, Schmid W, Zehetgruber M, Koller E.
    Thromb Res; 2000 Mar 15; 97(6):441-9. PubMed ID: 10704653
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function.
    Nordøy A, Svensson B, Wiebe D, Hoak JC.
    Circ Res; 1978 Oct 15; 43(4):527-34. PubMed ID: 210972
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Native and oxidized low density lipoproteins enhance platelet aggregation in whole blood.
    Tornvall P, Chirkova L, Toverud KD, Horowitz JD, Chirkov Y.
    Thromb Res; 1999 Aug 15; 95(4):177-83. PubMed ID: 10498387
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I, Koller E, Li S, Yang Q, Banyai M, Rauscha F, Pidlich J, Pirker W, Sinzinger H.
    Atherosclerosis; 1993 Sep 15; 102(2):217-26. PubMed ID: 8251008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.